Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Roivant Sciences (ROIV) Invested Capital: 2021-2025

Historic Invested Capital for Roivant Sciences (ROIV) over the last 5 years, with Sep 2025 value amounting to $4.8 billion.

  • Roivant Sciences' Invested Capital fell 13.88% to $4.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 billion, marking a year-over-year decrease of 13.88%. This contributed to the annual value of $5.2 billion for FY2025, which is 24.60% down from last year.
  • As of Q3 2025, Roivant Sciences' Invested Capital stood at $4.8 billion, which was down 0.22% from $4.8 billion recorded in Q2 2025.
  • Roivant Sciences' Invested Capital's 5-year high stood at $7.0 billion during Q4 2023, with a 5-year trough of $1.7 billion in Q3 2023.
  • Its 3-year average for Invested Capital is $4.7 billion, with a median of $5.2 billion in 2025.
  • As far as peak fluctuations go, Roivant Sciences' Invested Capital declined by 28.08% in 2022, and later surged by 287.73% in 2023.
  • Over the past 5 years, Roivant Sciences' Invested Capital (Quarterly) stood at $2.5 billion in 2021, then declined by 26.48% to $1.8 billion in 2022, then soared by 287.73% to $7.0 billion in 2023, then declined by 20.78% to $5.5 billion in 2024, then decreased by 13.88% to $4.8 billion in 2025.
  • Its last three reported values are $4.8 billion in Q3 2025, $4.8 billion for Q2 2025, and $5.2 billion during Q1 2025.